Amyloid-beta protein
-
A protein thought to play a critical role in the progression of Alzheimer’s disease may not originate where scientists thought, which could mean we may have to reconsider how we approach fighting this form of deadly neurodegeneration.
-
In a move that could drastically help slow the progression of Alzheimer's Disease (AD), the FDA has cleared C2N Diagnostics' PrecivityAD2 blood test for patients as young as 40 years who have shown potential cognitive symptoms of the condition.